Market News
Stay updated with the latest market trends, earnings, and economic indicators.
FirstCry shares fall 3% despite Q4 net loss narrowing to Rs 30 crore. What is Morgan Stanley saying?
FirstCry-parent Brainbees Solutions saw its shares dip over 3% despite a 61% narrowing of its Q4 net loss to Rs 30.30 crore. While revenue grew 12% year-on-year to Rs 2,163 crore, it declined sequentially. The company anticipates improved growth in FY27, with plans to expand its offline store presence.
Pine Labs shares rise over 4% after Q4 results. Why Morgan Stanley forecasts 67% upside
Pine Labs shares surged after the company reported a significant turnaround, posting a Rs 59 crore net profit in Q4FY26 against a loss last year. Full-year profits also swung to Rs 113 crore. Despite a recent share price dip, Morgan Stanley maintains an "Equal-weight" rating with a Rs 245 target, citing strong business growth.
Eicher Motors shares rally 5% after Q4 results. What Goldman Sachs, Morgan Stanley, others are saying
Eicher Motors shares surged following robust March quarter results. The Royal Enfield maker reported a 12% profit jump and 16% revenue growth. Analysts remain divided, with some recommending a buy and others a reduce. Capacity expansion is on track, but commodity costs and export uncertainties are noted.

Morgan Stanley stock hits all-time high at 201.84 USD - Investing.com India
Morgan Stanley stock hits all-time high at 201.84 USDInvesting.com India
Titan shares a golden compounder? Why Morgan Stanley thinks Tata Group stock could rally to Rs 5,182
Morgan Stanley has named Titan Company its top pick, calling it 'The Golden Compounder'. Recent concerns about regulatory restrictions have overshadowed the company's strong performance. Despite a recent duty hike on gold and silver, Morgan Stanley sees an attractive entry opportunity. Nomura also believes the impact on Titan is manageable. Organized players are expected to gain market share.
LG Electronics India shares fall 4% after Q4 results. What is Morgan Stanley saying?
LG India shares fell to ₹1,474 on BSE after Q4FY26 net profit dropped 8% YoY to ₹693 crore, even as revenue grew 8% to ₹8,054 crore. Sequentially, however, the picture was stronger — profit surged 672% and revenue nearly doubled QoQ from a weak Q3.
ITC shares fall 2% after Q4 results. What Goldman Sachs, Morgan Stanley and others are saying?
ITC shares slipped on Friday despite a 5% rise in Q4 standalone profit and strong FMCG growth. Brokerages remained cautious, with Goldman Sachs, Morgan Stanley, and Nomura flagging pressure from cigarette tax hikes. While FMCG and paper segments showed resilience, analysts expect cigarette volume decline and margin stress to weigh on earnings.
BSE vs MCX: Which stock are you betting on? Jefferies, Morgan Stanley, others have their say - The Economic Times
BSE vs MCX: Which stock are you betting on? Jefferies, Morgan Stanley, others have their sayThe Economic Times
BSE vs MCX: Which stock are you betting on? Jefferies, Morgan Stanley, others have their say
Amidst market volatility, Indian stock exchanges BSE and MCX have seen significant rallies, driven by increased trading activity. Both reported strong Q4 earnings. While Jefferies and ICICI Securities remain cautious on BSE, citing stagnant market share, brokerages like HDFC Securities and Morgan Stanley are more optimistic about MCX, highlighting its growth drivers in commodity trading.

OpenAI aiming for speedy IPO after court victory against Elon Musk, report suggests
OpenAI plans confidential US IPO filing within weeks, targeting a September listing with Goldman Sachs and Morgan Stanley, after beating Elon Musk lawsuit and amid rivalry with SpaceX IPO

Three Cybersecurity Stocks to Buy Ahead of Earnings, Ranked by Morgan Stanley - Investing.com India
Three Cybersecurity Stocks to Buy Ahead of Earnings, Ranked by Morgan StanleyInvesting.com India

OpenAI eyes confidential IPO filing as early as Friday
The AI company, valued at more than $850 billion by private investors, is reportedly working with Goldman Sachs and Morgan Stanley on the potential listing, according to a source familiar with the matter cited by CNBC.